This year, for the first time ever,
RNA Therapeutics is in association with
AI in Drug Discovery USA to create Drug Discovery Week. From October 21-25, 2024, as part of our renowned series of conferences, we will unite top experts from major pharma and biotech companies to network and share insights, advancing the development and application of
RNA Therapeutics and AI solutions.
Explore the latest advances in
RNA therapeutics, analytical and control processes, and vaccine development. Gain access to cutting-edge innovations in delivery technologies for precision targeting, with case studies on LNPs and more. Discover how AI can optimize drug discovery and delivery platforms, as well as formulation strategies to enhance therapeutic success.
Whether you're new to the RNA space or at the forefront of RNA innovation, our 2-day conference is designed to meet your needs with a comprehensive agenda exploring the latest in RNA research and development.
- Engage, Collaborate, and Learn: Connect with peers to exchange ideas, collaborate on projects, and learn from both the successes and challenges in RNA discovery, development, delivery, and manufacturing.
- Stay Ahead of the Curve: Dive into sessions covering breakthroughs in mRNA technology, innovative delivery systems, and cutting-edge therapeutic applications. Gain insights from leading pharmaceutical companies such as Pfizer, Moderna, Sanofi, and AstraZeneca.
- Drive Innovation: Participate in discussions on the future of RNA therapeutics, including the role of AI and machine learning in drug discovery and development. Learn how to overcome current challenges and leverage new opportunities to stay competitive in this fast-evolving field.
Join us in October!
Who Should Attend?
Join us at
RNA Therapeutics USA and immerse yourself in a hub of innovation and expertise. Engage directly with top-tier professionals including Directors, Heads, and Principal Scientists specializing in RNA Drug Delivery/Development, Genetic Medicine, Analytical Development, CMC/Manufacturing, and Drug Discovery. This event offers a rare platform to delve into the latest scientific breakthroughs, explore cutting-edge technologies, and discuss strategic insights with pioneers shaping the future of RNA therapeutics. Elevate your knowledge, spark new ideas, and discover collaborative opportunities that can accelerate your research and development projects.
Featured Speakers
- Confirmed Representative, BioPhorum
- Derek O Hagan, Senior Advisor R&D, GSK
- Heinrich Haas, Chief Technology Officer, NeoVac
- Hetal Patel, Senior Principle Scientist/Group Leader, Pfizer
- Jay Sarkar, Researcher and Entrepreneur, Stanford University
- Jim Weterings, Vice President R&D USA RNA Therapeutics & Delivery, Sirnaomics
- Kinkini Roy, Associate Director, Aviceda Therapeutics
- Martin Akerman, CTO & Co-Founder, Envisagenics
- Pushkar Saralkar, Senior Scientist, Pfizer
- Richard Geary, EVP, Chief Development Officer, Ionis Pharmaceuticals, Inc.
- Sandy Hinckley, VP, Head of Discovery, QurAlis Corporation
- Sourav Choudhury, Head AAV Technologies, Sanofi
- Steve Pascolo, Founder and CEO, Miescher Pharma GmbH
- Sudhir Agrawal, Founder and President, ARNAY Sciences
- Yue Hui, Scientist, Moderna
- Zdravka Medarova, Chief Scientific Officer, TransCode Therapeutics
- Zimeng Wang, Senior Scientist, AstraZeneca
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Courtyard by Marriott Boston Downtown
275 Tremont St, 02116
Boston, MA, USA
